2,4-Disubstituted thiazoles, Part III: Synthesis and antitumor activity of ethyl 2-substituted-aminothiazole-4-carboxylate analogs

Archiv der Pharmazie

Volumn 332, Issue 4, 1999, Pages 137-142

  El Subbagh, Hussein I ^a   Abadi, Ashraf H ^a   Lehmann, Jochen ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOTHIAZOLE 4 CARBOXYLIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; ETHYL 2 [3 (DIETHYLAMINO)PROPANAMIDO]THIAZOLE 4 CARBOXYLIC ACID; MELPHALAN; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032925404     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4184(19994)332:4<137::AID-ARDP137>3.0.CO;2-0     Document Type: Article

References (28)

1. H.I. El-Subbagh, W.A. El-Naggar, F.A. Badria, Med. Chem. Res. 1994, 3, 503.
2. R.C. Schnur, R.J. Gallaschun, D.H. Singleton, J. Med. Chem. 1991, 34, 1975.
3. th ACS National Meeting, Anaheim-CA, USA., 1995, April 2-6.
4. H.I. El-Subbagh, A.M. Al-Obaid, Eur. J. Med. Chem. 1996, 31, 1017.
5. Y. Kumar, R. Green, K.Z. Borysko, D.S. Wise, L.L. Wotring, L.B. Townsend, J. Med. Chem. 1993, 36, 3843.
6. G.J. Tricot, H.N. Jayaram, E. Lapis, Y. Natsumeda, C.R. Nichols, P Kneebone, N. Heerema, G. Weber, R. Hoffman, Cancer Res. 1989, 49, 3696.
7. B.M. Goldstein, J.F. Leary, B.A. Farley, V.E. Marquez, P.C. Levy, P.T. Rowley, Blood 1991, 78, 593.
8. C. Zimmer, U. Wahnert, Prog. Biophys. Mol. Biol. 1986, 47, 31.
9. B. Plouvier, R. Houssin, C. Baily, J. Henichart, J. Heterocyclic Chem. 1989, 26, 1643.
10. R.B. Silvermann, The Organic Chemistry of Drug Design and Drug Action; Academic Press; London 1992, p 263.
11. H. Umezawa, Y. Suhara, T. Taketa, K. Maeda, J. Antibiot. 1966, 19, 210.
12. H. Umezawa, S. Takeuchi, T. Hori, T. Sawa, T. Ishizuka, T. Komai, J. Antibiot. 1972, 25, 409.
13. H.I. El-Subbagh, F.A. Badria, Sci. Pharm. 1994, 62, 237.
14. H.I. El-Subbagh, M.A. El-Sherbeny, M.N. Nasr, F.E. Goda, F.A. Badria, Boll. Chim. Farmaceutico 1995, 134, 80.
15. I.A. Shehata, H.I. El-Subbagh, A.M. Abdelal, M.A. El-Sherbeny, A.M. Al-Obaid, Med. Chem. Res. 1996, 6, 148.
16. A.M. Al-Obaid, H.I. El-Subbagh, A.I. Khodair, M.M. El-Mazar, Anti-Cancer Drugs 1996, 7, 873.
17. H.I. El-Subbagh, Saudi Pharm. J. 1997, 5, 23.
18. A.I. Khodair, H.I. El-Subbagh, A.A. El-Emam, Boll. Chim. Farmaceutico 1997, 136, 561.
19. H.I. El-Subbagh, A.H. Abadi, H.A. Al-Khamees, Arch. Pharm. Pharm. Med. Chem., 1997, 330, 277.
20. H.I. El-Subbagh, Saudi Pharm. J. 1999, 7, in press.
21. A.H. Abadi, H.I. El-Subbagh, H.A. Al-Khamees, Arzneim-Forsch/Drug Res. 1999, in press.
22. A.H. Abadi and H.A. Al-Khamees, Arch. Pharm. Pharm. Med. Chem. 1998, 331, 319.
23. A.H. Abadi, Arch. Pharm. Pharm. Med. Chem. 1998, 331, 352.
24. M.R. Grever, S.A. Schepartz, B.A. Chabner, Seminar Oncol. 1992, 19, 622.
25. M.R. Boyd, K.D. Paul, Drug Rev. Res. 1995, 34, 91.
26. M.R. Boyd, K.D. Paull, L.R. Rubinstein, Data Display and Analysis Strategies for the NCI Disease-Oriented in vitro Antitumor Drug Screen, p. 11, Klauer Academic Publisher, Amsterdam 1992.
27. A. Monks, D. Scudiero, P. Skehan, et al., J. Natl. Cancer Inst. 1991, 83, 757.
28. R. Kuhn and K. Dury, Ann. Chem. 1951, 571, 44.